View in EDS HTML Full Text PDF Full Text

The immediate-early protein 1 of human herpesvirus 6B interacts with NBS1 and inhibits ATM signaling.

Saved in:
Bibliographic Details
Title: The immediate-early protein 1 of human herpesvirus 6B interacts with NBS1 and inhibits ATM signaling.
Authors: Collin V; Division of Infectious Disease and Immunity, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1V 4G2, Canada.; Department of Microbiology, Infectious Disease and Immunology, Faculty of Medicine, Université Laval, Quebec City, QC, G1V 0A6, Canada., Biquand É; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada.; INSERM, Centre d'Étude des Pathologies Respiratoires (CEPR), UMR 1100, Université de Tours, Tours, France., Tremblay V; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada., Lavoie ÉG; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada., Blondeau A; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada., Gravel A; Division of Infectious Disease and Immunity, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1V 4G2, Canada.; Department of Microbiology, Infectious Disease and Immunology, Faculty of Medicine, Université Laval, Quebec City, QC, G1V 0A6, Canada., Galloy M; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada., Lashgari A; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada., Dessapt J; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada., Côté J; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada., Flamand L; Division of Infectious Disease and Immunity, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1V 4G2, Canada. louis.flamand@crchudequebec.ulaval.ca.; Department of Microbiology, Infectious Disease and Immunology, Faculty of Medicine, Université Laval, Quebec City, QC, G1V 0A6, Canada. louis.flamand@crchudequebec.ulaval.ca., Fradet-Turcotte A; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada. amelie.fradet-turcotte@crchudequebec.ulaval.ca.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada. amelie.fradet-turcotte@crchudequebec.ulaval.ca.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada. amelie.fradet-turcotte@crchudequebec.ulaval.ca.
Source: EMBO reports [EMBO Rep] 2024 Feb; Vol. 25 (2), pp. 725-744. Date of Electronic Publication: 2024 Jan 02.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 100963049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-3178 (Electronic) Linking ISSN: 1469221X NLM ISO Abbreviation: EMBO Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38177923
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The immediate-early protein 1 of human herpesvirus 6B interacts with NBS1 and inhibits ATM signaling.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Collin+V%22">Collin V</searchLink>; Division of Infectious Disease and Immunity, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1V 4G2, Canada.; Department of Microbiology, Infectious Disease and Immunology, Faculty of Medicine, Université Laval, Quebec City, QC, G1V 0A6, Canada.<br /><searchLink fieldCode="AU" term="%22Biquand+É%22">Biquand É</searchLink>; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada.; INSERM, Centre d'Étude des Pathologies Respiratoires (CEPR), UMR 1100, Université de Tours, Tours, France.<br /><searchLink fieldCode="AU" term="%22Tremblay+V%22">Tremblay V</searchLink>; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada.<br /><searchLink fieldCode="AU" term="%22Lavoie+ÉG%22">Lavoie ÉG</searchLink>; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada.<br /><searchLink fieldCode="AU" term="%22Blondeau+A%22">Blondeau A</searchLink>; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada.<br /><searchLink fieldCode="AU" term="%22Gravel+A%22">Gravel A</searchLink>; Division of Infectious Disease and Immunity, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1V 4G2, Canada.; Department of Microbiology, Infectious Disease and Immunology, Faculty of Medicine, Université Laval, Quebec City, QC, G1V 0A6, Canada.<br /><searchLink fieldCode="AU" term="%22Galloy+M%22">Galloy M</searchLink>; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada.<br /><searchLink fieldCode="AU" term="%22Lashgari+A%22">Lashgari A</searchLink>; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada.<br /><searchLink fieldCode="AU" term="%22Dessapt+J%22">Dessapt J</searchLink>; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada.<br /><searchLink fieldCode="AU" term="%22Côté+J%22">Côté J</searchLink>; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada.<br /><searchLink fieldCode="AU" term="%22Flamand+L%22">Flamand L</searchLink>; Division of Infectious Disease and Immunity, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1V 4G2, Canada. louis.flamand@crchudequebec.ulaval.ca.; Department of Microbiology, Infectious Disease and Immunology, Faculty of Medicine, Université Laval, Quebec City, QC, G1V 0A6, Canada. louis.flamand@crchudequebec.ulaval.ca.<br /><searchLink fieldCode="AU" term="%22Fradet-Turcotte+A%22">Fradet-Turcotte A</searchLink>; Oncology Division, Centre Hospitalier Universitaire (CHU) de Québec-Université Laval Research Center, Quebec City, QC, G1R 2J6, Canada. amelie.fradet-turcotte@crchudequebec.ulaval.ca.; Department of Molecular biology, Medical Biochemistry and Pathology, Faculty of Medicine, Université Laval, Québec City, QC, G1V 0A6, Canada. amelie.fradet-turcotte@crchudequebec.ulaval.ca.; Université Laval Cancer Research Center, Université Laval, Quebec City, QC, G1R 3S3, Canada. amelie.fradet-turcotte@crchudequebec.ulaval.ca.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100963049%22">EMBO reports</searchLink> [EMBO Rep] 2024 Feb; Vol. 25 (2), pp. 725-744. <i>Date of Electronic Publication: </i>2024 Jan 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100963049 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1469-3178 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221469221X%22">1469221X </searchLink><i>NLM ISO Abbreviation: </i>EMBO Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38177923
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s44319-023-00035-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 725
    Titles:
      – TitleFull: The immediate-early protein 1 of human herpesvirus 6B interacts with NBS1 and inhibits ATM signaling.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Collin V
      – PersonEntity:
          Name:
            NameFull: Biquand É
      – PersonEntity:
          Name:
            NameFull: Tremblay V
      – PersonEntity:
          Name:
            NameFull: Lavoie ÉG
      – PersonEntity:
          Name:
            NameFull: Blondeau A
      – PersonEntity:
          Name:
            NameFull: Gravel A
      – PersonEntity:
          Name:
            NameFull: Galloy M
      – PersonEntity:
          Name:
            NameFull: Lashgari A
      – PersonEntity:
          Name:
            NameFull: Dessapt J
      – PersonEntity:
          Name:
            NameFull: Côté J
      – PersonEntity:
          Name:
            NameFull: Flamand L
      – PersonEntity:
          Name:
            NameFull: Fradet-Turcotte A
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2024 Feb
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1469-3178
          Numbering:
            – Type: volume
              Value: 25
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: EMBO reports
              Type: main
ResultId 1